Avenue Therapeutics, Inc.
ATXI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001644963
No open-market purchases or sales by Avenue Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Avenue Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −5 vs. Q1 2021
- Shares held
- 1.15M
- −685.5K (−37.3%) vs. Q1 2021
- Total value
- $2.88M
- −$8.26M (−74.1%) vs. Q1 2021
- New holders
- 10
- 4 more added
- Sold out
- 15
- 13 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATXI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 7 | $385.3K |
| Q3 2024 | 8 | $491.8K |
| Q2 2024 | 9 | $407.2K |
| Q1 2024 | 14 | $168.9K |
| Q4 2023 | 15 | $52.4K |
| Q3 2023 | 14 | $157.3K |
| Q2 2023 | 12 | $849.4K |
| Q1 2023 | 14 | $532.7K |
| Q4 2022 | 14 | $520.5K |
| Q3 2022 | 11 | $766.0K |
| Q2 2022 | 19 | $181.0K |
| Q1 2022 | 17 | $503.0K |
| Q4 2021 | 18 | $2.14M |
| Q3 2021 | 21 | $1.62M |
| Q2 2021 | 29 | $2.88M |
| Q1 2021 | 34 | $11.1M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Avenue Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 449,982 | $1.13M | 0.00% | −248,151−35.5% | Reduced |
| National Asset Management, Inc. | 126,037 | $317.0K | 0.01% | −44,450−26.1% | Reduced |
| Geode Capital Management, LLC | 79,556 | $199.0K | 0.00% | −53,038−40.0% | Reduced |
| Renaissance Technologies LLC | 78,314 | $197.0K | 0.00% | +78,314 | New |
| Millennium Management LLC | 72,889 | $183.0K | 0.00% | +72,889 | New |
| BlackRock Inc. | 47,958 | $120.0K | 0.00% | −314,936−86.8% | Reduced |
| Emfo, LLC | 43,590 | $109.0K | 0.10% | +43,590 | New |
| Advisory Services Network, LLC | 35,121 | $88.0K | 0.00% | +35,121 | New |
| Nantahala Capital Management, LLC | 30,211 | $76.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 30,400 | $76.0K | 0.00% | +30,400 | New |
| Virtu Financial LLC | 26,373 | $66.0K | 0.01% | +26,373 | New |
| HRT Financial LP | 24,620 | $61.0K | 0.00% | +24,620 | New |
| Goldman Sachs Group Inc | 23,224 | $58.0K | 0.00% | +5,905+34.1% | Added |
| Occudo Quantitative Strategies LP | 14,398 | $36.0K | 0.01% | +14,398 | New |
| Northern Trust Corp | 13,767 | $35.0K | 0.00% | −63,282−82.1% | Reduced |
| Jane Street Group, LLC | 13,359 | $34.0K | 0.00% | +13,359 | New |
| Tower Research Capital LLC (TRC) | 11,373 | $29.0K | 0.00% | +8,564+304.9% | Added |
| XTX Topco Ltd | 10,864 | $27.0K | 0.01% | +10,864 | New |
| Parametric Portfolio Associates LLC | 10,554 | $26.0K | 0.00% | −15,314−59.2% | Reduced |
| Barclays PLC | 2,078 | $5.00K | 0.00% | −3,490−62.7% | Reduced |
| Bank of America Corp | 1,694 | $4.00K | 0.00% | −8,550−83.5% | Reduced |
| UBS Group AG | 1,331 | $3.00K | 0.00% | −4,311−76.4% | Reduced |
| Royal Bank of Canada | 1,255 | $3.00K | 0.00% | +495+65.1% | Added |
| JPMorgan Chase & Co | 665 | $2.00K | 0.00% | −17,545−96.3% | Reduced |
| BNP Paribas Arbitrage, SA | 133 | $334 | 0.00% | −669−83.4% | Reduced |
| New York State Common Retirement Fund | 60 | $0 | 0.00% | −6,740−99.1% | Reduced |
| Wells Fargo & Company | 42 | $0 | 0.00% | −3,645−98.9% | Reduced |
| The PNC Financial Services Group, Inc. | 198 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 183 | $0 | 0.00% | +108+144.0% | Added |
| State Street Corp | 0 | $0 | 0.00% | −143,801−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −30,629−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −16,232−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −14,848−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −14,314−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −13,874−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,668−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −10,047−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −4,336−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −3,884−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −853−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −589−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −443−100.0% | Sold out |
| Berman Capital Advisors, LLC | 0 | $0 | 0.00% | −610−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −216−100.0% | Sold out |